GILD Price Profile
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Gilead Sciences (GILD) company profile
Gilead Sciences Inc. (NASDAQ: GILD) is a biopharmaceutical company that researches, develops, and commercializes medicines. The company focuses on advancing medicines to prevent and treat diseases like human immunodeficiency virus (HIV), viral hepatitis, and cancer. The company has existing collaboration with Arcus Biosciences, Pionyr; Tizona; Tango Therapeutics, Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S.